Reuters logo
3 个月前
BRIEF-Fennec reports Q1 loss per share $0.06
2017年5月12日 / 上午10点09分 / 3 个月前

BRIEF-Fennec reports Q1 loss per share $0.06

May 12 (Reuters) - Fennec Pharmaceuticals Inc-

* Fennec provides corporate update and announces first quarter 2017 results

* Fennec Pharmaceuticals Inc - research and development expenses for three months ended march 31, 2017 were $0.2 million above same period in prior year

* Fennec Pharmaceuticals Inc qtrly loss per share $0.06

* Fennec Pharmaceuticals -at march 31, 2017, company had working capital balance totaling approximately $2.9 million compared to $3.6 million as of dec 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below